Abstract
A novel antitumor compound, N‐β‐dimethylaminoethyl 9‐carboxy‐5‐hydroxy‐10‐methoxybenzo[a]‐phenazine‐6‐carboxamide sodium salt (NC‐190), was evaluated for antitumor activity in vitro against cultured tumor cell lines, and the kinetics of cell killing was elucidated. NC‐190 strongly inhibited the growth of all of 3 murine tumor cell lines, 7 human tumor cell lines and 2 normal cell lines. With continuous exposure, the 50% inhibition concentrations were in the range of 0.005–0.06 μg/ml, except for KATO‐III (2.15 μ g/ml). By colony‐forming assay, concentrations of NC‐190 giving 90% cell kill (IC90) at various exposure times were obtained with HeLa S3 cells. The plot of IC90exposure time on a log‐log scale was linear for NC‐190 with a slope of ‐1, which is typical for cell cycle phase‐nonspecific agents. A 2 h treatment with NC‐190 induced a rapid reduction in cell viability at doses of more than 3 μ g/ml. At the dose where colony formation was completely inhibited, cell viability was persistently reduced to below 20% during the cell culture period. NC‐190 cauced a dose‐ and time‐dependent reduction in DNA synthesis. The inhibitions of RNA and protein synthesis were less than that of DNA synthesis. Spectroscopic studies of NC‐190 mixed with calf thymus DNA demonstrated that NC‐190 was capable of interacting with DNA. However, DNA thermal denaturation studies suggested that intercalation of NC‐190 was weak in comparison with those of classical intercalating drugs.
Keywords: Key words, NC‐190, Benzo [a] phenazine derivative, Antitumor activity, Kinetic analysis, Cultured tumor cell, Kinetic analysis
Full Text
The Full Text of this article is available as a PDF (475.7 KB).
REFERENCES
- 1. ) Nakaike , S. , Yamagishi , T. , Samata , K. , Nishida , K. , Inazuki , K. , Ichihara , T. , Migita , Y. , Otomo , S. , Aihara , H. and Tsukagoshi , S.In vivo activity on murine tumors of a novel antitumor compound, N‐β‐dimethylaminoethyl 9‐carboxy‐5‐hydroxy‐10‐methoxybenzo [a] phenazine‐6‐carboxamide sodium salt (NC‐190) . Cancer Chemother. Pharmacol , 23 , 135 – 139 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Tsuruo , T. , Naito , M. , Takamori , R. , Tsukahara , S. , Yamabe‐Mitsuhashi , J. , Yamazaki , A. , Oh‐hara , T. , Sudo , Y. , Nakaike , S. and Yamagishi , T.A benzophenazine derivative, N‐β‐dimethylaininoethyl 9‐carboxy‐5‐hydroxy‐10‐methoxybenzo[a]phenazine‐6‐carboxamide, as a new antitumor agent against multidrug‐resistant and sensitive tumors . Cancer Chemother. Pharmacol. , 26 , 83 – 87 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Ozawa , S. , Sugiyama , Y. , Mitsuhashi , Y. , Kobayashi , T. and Inaba , M.Cell killing action of cell cycle phase‐nonspecific antitumor agents is dependent on concentration‐time product . Cancer Chemother. Pharmacol , 21 , 185 – 190 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Shimoyama , M.Cytocidal action of anticancer agents: evaluation of the sensitivity of cultured animal and human cancer cells . In “ Comparative Leukemia Research 1973, Leukemogenesis ,” ed. Ito Y. and Dutcher R. M. , pp. 711 – 722 ( 1975. ). University of Tokyo Press; , Tokyo . [DOI] [PubMed] [Google Scholar]
- 5. ) Zunino , F. , Gambetta , R. , Di Marco , A. and Zaccara , A.Interaction of daunomycin and its derivatives with DNA . Biochim. Biophys. Acta , 277 , 489 – 498 ( 1972. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Ozawa , S. , Sugiyama , Y. , Mitsuhashi , J. and Inaba , M.Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells . Cancer Res. , 49 , 3823 – 3828 ( 1989. ). [PubMed] [Google Scholar]
- 7. ) Gray , H. B.Jr. , Upholt , W. B. and Vinograd , J.Buoyant method for the determination of the superhelix density of closed circular DNA . J. Mol. Biol , 62 , 1 – 19 ( 1971. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Nakaike , S. , Samata , K. , Ichihara , T. , Kohno , Y. , Masuda , N. , Otomo , S. and Tsukagoshi , S.Antitumor effect of NC‐190. (4) Antitumor activity and tissue distribution in Lewis lung carcinoma bearing mice . Proc. Jpn. Cancer Assoc, 47th Annu. Meet , 581 ( 1988. ).
- 9. ) Gupta , R. S.Species‐specific differences in toxicity of antimitotic agents toward cultured mammalian cells . J. Natl. Cancer Inst. , 74 , 159 – 164 ( 1985. ). [PubMed] [Google Scholar]
- 10. ) Inaba , M. , Mitsuhashi , J. and Ozawa , S.Kinetic analysis of 5‐fluorouracil action against various cancer cells . Jpn. J. Cancer Res. , 81 , 1039 – 1044 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. ) Andoh , T. , Ikegami , Y. , Ono , K. , Ikeda , T. , Yamagishi , T. and Nakaike , S.Inhibitory effects of the novel antitumor compound NC‐190 on DNA topoisomerases . Proc. Jpn. Cancer Assoc, 49th Annu. Meet. , 410 ( 1990. ).
- 12. ) Porumb , H.The solution spectroscopy of drugs and the drug‐nucleic acid interactions . Prog. Biophys. Mol. Biol , 34 , 175 – 195 ( 1978. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Kapuscinski , J. , Darzynkiewicz , Z. , Traganos , F. and Melamed , M. R.Interactions of a new antitumor agent, 1,4 ‐ dihydroxy ‐ 5,8 ‐ bis[[(2 ‐ [(2 ‐ hydroxyethyl)amino]‐ethyl]‐amino]‐9,10‐anthracenedione, with nucleic acids . Biochem. Pharmacol , 30 , 231 – 240 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Hartley , J. A. , Reszka , K. , Zuo , E. T. , Wilson , D. , Morgan , A. R. and Lown , J. W.Characteristics of the interaction of anthrapyrazole anticancer agents with de‐oxyribonucleic acids: structural requirements for DNA binding, interaction, and photosensitization . Mol. Pharmacol. , 33 , 265 – 271 ( 1988. ). [PubMed] [Google Scholar]
- 15. ) Double , J. C. and Brown , J. R.The interaction of amino‐alkylaminoanthraquinones with deoxyribonucleic acid . J. Pharm. Pharmacol , 27 , 502 – 507 ( 1975. ). [DOI] [PubMed] [Google Scholar]